中药联合依巴斯汀治疗面部糖皮质激素依赖性皮炎  被引量:6

Traditional Chinese Medicine Combined with Ebastine in the Treatment of Facial Steroid Dependent Dermatitis

在线阅读下载全文

作  者:肖茜[1] XIAO Qian(Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032,Shaanxi,China)

机构地区:[1]第四军医大学西京皮肤医院,陕西西安710032

出  处:《中国美容医学》2018年第2期130-132,共3页Chinese Journal of Aesthetic Medicine

基  金:陕西省重点研发计划项目(2017SF-318);陕西省中医管理局中医药科研课题(JCMS049)

摘  要:目的:探讨中药清热止痒方联合依巴斯汀治疗血热型面部糖皮质激素依赖性皮炎的有效性及安全性,评价其临床应用价值。方法:临床应用自拟中药清热止痒方内服外用联合依巴斯汀治疗血热型糖皮质激素依赖性皮炎,并与单用依巴斯汀治疗进行疗效比较,观察其疗效和患者满意率。结果:单用依巴斯汀治疗组有效率为60.0%,中药清热止痒方内服外用联合依巴斯汀对照组有效率为82.1%,两组有效率比较,差异有显著性(P<0.05)。联合应用组患者满意率较高。结论:中药清热止痒方内服外用联合依巴斯汀治疗血热型面部糖皮质激素依赖性皮炎疗效良好,安全无副作用,患者满意率高,值得临床推广使用。Objective Study of Qingre Zhiyang Fang efficacy and safety of combined with Ebastine in treatment of blood-heat type of facial steroid dependent dermatitis treatment,to evaluate its clinical value.Methods The clinical application of Chinese medicine prescription Qingre Zhiyang oral topical combined with Ebastine in treatment of blood-heat type of facial steroid dependent dermatitis.To observe the curative effect of Qingre Zhiyang Fang combined with Ebastine in treatment of blood-heattype of facial steroid dependent dermatitis.Results Single use of ebastine in the treatment group was60%,Qingre Zhiyang Fang herbs combined with Ebastine in treatment group was82.1%,the effective rates of the two groups were statistically significant(P<0.05),between the two groups to compare efficiency had significant difference statistically significant(P<0.05).Conclusion To judge the curative effect of two groups,Qingre Zhiyang Fang herbs combined with Ebastine in treatment of blood-heat type of facial steroid dependent dermatitis treatment,good effect,safety and no side effects,is worthy of clinical use.

关 键 词:中药 依巴斯汀 糖皮质激素依赖性皮炎 疗效观察 

分 类 号:R758.22[医药卫生—皮肤病学与性病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象